Skip to main content

Table 3 Pooled effect of HBV/HCV coinfection studies with HCV mono-infection control studies

From: The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis

Effects

HBV/HCV

HCV

Effect size

Heterogeneity

 

Studies (n)

Sample size

Events

Sample size

Events

OR(95% CI)

P

I 2

P

ETVR

4

271

233

308

266

1.03(0.37-2.82)

0.96

69%

0.02

SVR

5

313

213

392

276

0.87(0.62-1.21)

0.38

0%

0.61

HCV relapse

4

270

49

308

42

1.55(0.98-2.47)

0.06

47%

0.13

HCV genotype 1 relapse

2

127

27

135

13

2.4(1.17-4.91)

0.19

74%

0.05

HCV non-genotype 1 relapse

2

84

7

71

7

0.9(0.3-2.71)

0.85

0%

0.4o

  1. OR odds ratio.